LoperamideThird Party Manufacturing in India

Loperamide is a synthetic phenylpiperidine opioid that acts as a μ-opioid receptor agonist in the gastrointestinal tract. At therapeutic doses, it binds directly to opioid receptors on the circular and longitudinal smooth muscle layers of the intestinal wall, inhibiting the release of acetylcholine and prostaglandins. This reduces propulsive peristalsis, prolongs intestinal transit time, and allows more water and electrolytes to be absorbed from the stool. Loperamide also increases the tone of the anal sphincter, which helps reduce fecal incontinence and urgency. Unlike other opioid agonists, loperamide is a substrate for P-glycoprotein, which actively transports it back into the intestinal lumen after absorption and prevents significant penetration across the blood-brain barrier at recommended doses. This unique property gives loperamide its peripheral selectivity, providing antidiarrheal efficacy without central nervous system effects such as sedation or euphoria. It reduces daily fecal volume, increases stool viscosity and bulk density, and diminishes the loss of fluid and electrolytes during diarrheal episodes.

Therapeutic Uses

Loperamide is prescribed for the treatment of:

• Acute Nonspecific Diarrhea: Symptomatic relief of acute diarrhea in patients two years of age and older, including traveler's diarrhea.
• Chronic Diarrhea: Management of chronic diarrhea associated with inflammatory bowel disease, including Crohn's disease and ulcerative colitis.
• Ileostomy Output Reduction: Decreases the volume and frequency of discharge from ileostomies, improving patient quality of life.
• Chemotherapy-Induced Diarrhea: Off-label use for managing diarrhea associated with cancer treatment, particularly with immune checkpoint inhibitors and targeted therapies.

Why Manufacturers Choose Loperamide

Loperamide is a high-volume over-the-counter antidiarrheal available in most global markets without prescription, driving consistent consumer demand. Its well-established safety profile at recommended doses and peripheral selectivity make it a trusted choice for both pediatric and adult formulations. Indian manufacturers benefit from the molecule's low manufacturing cost and high volume turnover, making it ideal for PCD franchise distribution chains and supermarket pharmacy channels. The standard 2mg tablet is universally recognized, and the molecule can also be formulated as capsules, oral liquids, and combination products with simethicone for added market differentiation.